Pathogenesis and prevention of chronic lung disease in the neonate

Debbie Fraser Askin1, William Diehl-Jones

  • 1Faculty of Nursing, University of Manitoba, Winnipeg, Manitoba, Canada. debbie_fraser@umanitoba.ca

Insights

Chronic lung disease (CLD), also known as bronchopulmonary dysplasia (BPD), affects premature infants. This review explores its causes, lung development, and current prevention and treatment strategies.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology

Background:

  • Bronchopulmonary dysplasia (BPD), or chronic lung disease (CLD), is a significant cause of morbidity and mortality in extremely low birth weight infants (<1000 g).
  • It often develops in infants requiring prolonged oxygen therapy and positive pressure ventilation.
  • Despite research, the exact etiology and pathogenesis of BPD remain incompletely understood.

Purpose of the Study:

  • To review the embryologic development of the lung in relation to BPD.
  • To discuss the pathogenesis of CLD/BPD.
  • To examine current and historical measures for BPD prevention and treatment.

Main Methods:

  • Literature review of embryologic lung development.
  • Review of pathogenesis studies for CLD/BPD.
  • Synthesis of data on preventative and therapeutic interventions for BPD.

Main Results:

  • The review details lung development and how it is disrupted in BPD.
  • Pathogenic mechanisms contributing to CLD/BPD are discussed.
  • Various strategies for preventing and treating BPD are presented.

Conclusions:

  • Understanding lung development and pathogenesis is crucial for addressing BPD.
  • Continued research is needed to improve preventative and therapeutic approaches for BPD in vulnerable infants.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...